Ameriprise’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-33,435
| Closed | -$557K | – | 3803 |
|
|
2017
Q3 | $557K | Hold |
33,435
| – | – | ﹤0.01% | 3181 |
|
|
2017
Q2 | $599K | Sell |
33,435
-28,865
| -46% | -$539K | ﹤0.01% | 3167 |
|
|
2017
Q1 | $1.25M | Sell |
62,300
-11,739
| -16% | -$273K | ﹤0.01% | 2792 |
|
|
2016
Q4 | $1.85M | Sell |
74,039
-21,781
| -23% | -$515K | ﹤0.01% | 2663 |
|
|
2016
Q3 | $2.24M | Sell |
95,820
-29,837
| -24% | -$701K | ﹤0.01% | 2517 |
|
|
2016
Q2 | $2.51M | Sell |
125,657
-38,532
| -23% | -$719K | ﹤0.01% | 2408 |
|
|
2016
Q1 | $2.78M | Buy |
164,189
+20,389
| +14% | +$418K | ﹤0.01% | 2332 |
|
|
2015
Q4 | $3.19M | Sell |
143,800
-9,000
| -6% | -$187K | ﹤0.01% | 2342 |
|
|
2015
Q3 | $2.59M | Sell |
152,800
-110,861
| -42% | -$1.73M | ﹤0.01% | 2471 |
|
|
2015
Q2 | $3.62M | Sell |
263,661
-147,929
| -36% | -$1.97M | ﹤0.01% | 2358 |
|
|
2015
Q1 | $5.63M | Buy |
411,590
+81,781
| +25% | +$944K | ﹤0.01% | 2028 |
|
|
2014
Q4 | $3.49M | Buy |
329,809
+217,809
| +194% | +$2.58M | ﹤0.01% | 2280 |
|
|
2014
Q3 | $1.4M | Buy |
112,000
+111,900
| +111,900% | +$1.56M | ﹤0.01% | 2648 |
|
|
2014
Q2 | $1K | Sell |
100
-17,961
| -99% | -$235K | ﹤0.01% | 5443 |
|
|
2014
Q1 | $218K | Buy |
18,061
+17,961
| +17,961% | +$206K | ﹤0.01% | 3216 |
|
|
2013
Q4 | $1K | Sell |
100
-1,241
| -93% | -$14.6K | ﹤0.01% | 5042 |
|
|
2013
Q3 | $14K | Sell |
1,341
-8,040
| -86% | -$75.2K | ﹤0.01% | 4675 |
|
|
2013
Q2 | $84K | Buy |
+9,381
| New | +$94.5K | ﹤0.01% | 3456 |
|
Ameriprise's OME Position: Q4 2017 in Review
Ameriprise sold out of Omega Protein (OME) in Q4 2017, closing a stake of 33,435 shares — an estimated $557K sold.
Ameriprise first reported a position in OME in Q2 2013 and held it in 18 quarters. The position peaked at $5.63M in Q1 2015. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- Ameriprise reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- Ameriprise sold 33,435 Omega Protein shares in Q4 2017, an estimated $557K.
- Ameriprise first reported a position in Omega Protein in Q2 2013 and held it in 18 quarters.
- Ameriprise's Omega Protein position peaked at $5.63M in Q1 2015.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on Ameriprise's 13F filing for Q4 2017, filed 12 Feb 2018.